{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:57:09Z","timestamp":1770508629317,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T00:00:00Z","timestamp":1254700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T00:00:00Z","timestamp":1254700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/bmt.2009.272","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T16:50:40Z","timestamp":1254761440000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT"],"prefix":"10.1038","volume":"45","author":[{"given":"R de la","family":"C\u00e1mara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F J","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,5]]},"reference":[{"key":"BFbmt2009272_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/510592","volume":"44","author":"A Upton","year":"2007","unstructured":"Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA . Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531\u2013540.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2009272_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005; 36: 757\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009272_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","volume":"102","author":"T Fukuda","year":"2003","unstructured":"Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after non-myeloablative conditioning. Blood 2003; 102: 827\u2013833.","journal-title":"Blood"},{"key":"BFbmt2009272_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.bmt.1703738","volume":"30","author":"E Jantunen","year":"2002","unstructured":"Jantunen E, Anttila VJ, Ruutu T . Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress? Bone Marrow Transplant 2002; 30: 925\u2013929.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2009272_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/504490","volume":"43","author":"MA Pfaller","year":"2006","unstructured":"Pfaller MA, Pappas PG, Wingard JR . Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43 (Suppl 1): S3\u2013S14.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2009272_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2141.2007.06812.x","volume":"139","author":"PD Barnes","year":"2007","unstructured":"Barnes PD, Marr KA . Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519\u2013531.","journal-title":"Br J Haematol"},{"key":"BFbmt2009272_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM . Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358\u2013366.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2009272_CR8","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068\u20131075.","journal-title":"Haematologica"},{"key":"BFbmt2009272_CR9","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cncr.23466","volume":"112","author":"R Hachem","year":"2008","unstructured":"Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I . The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112: 2493\u20132499.","journal-title":"Cancer"},{"key":"BFbmt2009272_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00277-004-0909-0","volume":"84","author":"M Ortega","year":"2005","unstructured":"Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Mart\u00ednez JA et al. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005; 84: 40\u201346.","journal-title":"Ann Hematol"},{"key":"BFbmt2009272_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"T Walsh","year":"2008","unstructured":"Walsh T, Anaissie E, Denning D, Herbrecht R, Kontoyiannis D, Marr K et al. Treatment of aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327\u2013360.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2009272_CR12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/infdis\/171.6.1545","volume":"171","author":"MA Slavin","year":"1995","unstructured":"Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1515\u20131552.","journal-title":"J Infect Dis"},{"key":"BFbmt2009272_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJM199203263261301","volume":"326","author":"JL Goodman","year":"1992","unstructured":"Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845\u2013851.","journal-title":"N Engl J Med"},{"key":"BFbmt2009272_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejcsup.2007.06.005","volume":"5","author":"O Marchetti","year":"2007","unstructured":"Marchetti O, Cordonnier C, Calandra T . Empirical antifungal therapy in neutropoenic cancer patients with persistent fever. Eur J Cancer Supplements 2007; 5: 32\u201342.","journal-title":"Eur J Cancer Supplements"},{"key":"BFbmt2009272_CR15","unstructured":"National Comprehensive Cancer Network. Prevention and treatment of cancer-related infection NCCN V 1 2008. NCCN Clinical Practice Guidelines in Oncology. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/infections.pdf."},{"key":"BFbmt2009272_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335\u2013347.","journal-title":"N Engl J Med"},{"key":"BFbmt2009272_CR17","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2005","unstructured":"Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL . Methods for the Economic Evaluation of Health Care Programmes, 3rd edn Oxford University Press: Oxford, 2005."},{"key":"BFbmt2009272_CR18","unstructured":"National Marrow Donor Program. Graft-versus-host disease. 2006 Available at http:\/\/www.marrow.org."},{"key":"BFbmt2009272_CR19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V74.4.1428.1428","volume":"74","author":"JR Wingard","year":"1989","unstructured":"Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989; 74: 1428\u20131435.","journal-title":"Blood"},{"key":"BFbmt2009272_CR20","unstructured":"National Statistics Institute. Vital statistics Deaths according to age. Available at http:\/\/www.ine.es."},{"key":"BFbmt2009272_CR21","unstructured":"Database of Medicines of the Spanish General Council of Pharmacists Available at http:\/\/www.portalfarma.com."},{"key":"BFbmt2009272_CR22","unstructured":"Soikos. Base de Datos de Costes Sanitarios. Soikos: Barcelona, 2005."},{"key":"BFbmt2009272_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1130-6343(05)73629-1","volume":"29","author":"S Grau Cerrato","year":"2005","unstructured":"Grau Cerrato S, Mateu de Antonio J, Soto Alvarez J, Mu\u00f1oz Jare\u00f1o MA, Salas S\u00e1nchez E, Mar\u00edn-Casino M et al. Evaluaci\u00f3n econ\u00f3mica del uso de voriconazol versus anfotericina B en el tratamiento de la aspergilosis invasiva. Farm Hosp 2005; 29: 5\u201310.","journal-title":"Farm Hosp"},{"key":"BFbmt2009272_CR24","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-effectiveness in Health and Medicine. Oxford University Press: New York, 1996."},{"key":"BFbmt2009272_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0213-9111(02)71933-X","volume":"16","author":"JA Sacrist\u00e1n","year":"2002","unstructured":"Sacrist\u00e1n JA, Oliva J, Del Llano J, Priet L, Pinto JL . \u00bfQu\u00e9 es una tecnolog\u00eda eficiente en Espa\u00f1a? Gac Sanit 2002; 16: 334\u2013343.","journal-title":"Gac Sanit"},{"key":"BFbmt2009272_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/bmj.319.7202.120","volume":"319","author":"A Briggs","year":"1999","unstructured":"Briggs A . Handling uncertainty in economic evaluation. Br Med J 1999; 319: 120.","journal-title":"Br Med J"},{"key":"BFbmt2009272_CR27","first-page":"979A","volume":"110","author":"AK \u00d3Sullivan","year":"2007","unstructured":"\u00d3Sullivan AK, Weinstein MC, Panday A, Thompson D, Langston A, Perfect J et al. Cost-effectiveness of posaconazole vs fluconazole in the prevention of invasive fungal infections among patients with graft-versus-host disease (GVHD) in the US. Blood (ASH Annu Meet Abstr) 2007; 110: 979A (abstr. 3336).","journal-title":"Blood (ASH Annu Meet Abstr)"},{"key":"BFbmt2009272_CR28","doi-asserted-by":"publisher","first-page":"A97","DOI":"10.1016\/S1098-3015(10)70314-4","volume":"11","author":"AA Tahami Monfared","year":"2008","unstructured":"Tahami Monfared AA, O'Sullivan AK, Papadopoulos G . Cost-effectiveness of posaconazole vs fluconazole in the prophylaxis against invasive fungal infections in patients with graft-versus-host disease in Canada. Value in Health 2008; 11: A97 (abstr. PIN16).","journal-title":"Value in Health"},{"issue":"Suppl 1","key":"BFbmt2009272_CR29","first-page":"S339","volume":"41","author":"R Greiner","year":"2008","unstructured":"Greiner R, Meier Y, O'Sullivan A, Imhof A . Cost effectiveness of posaconazole versus standard azole therapy for the prevention of invasive fungal infections in high-risk patients in Switzerland. Bone Marrow Transplant 2008; 41 (Suppl 1): S339 (abstr. P1069).","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2009272_CR30","first-page":"S235","volume":"41","author":"JP Jansen","year":"2008","unstructured":"Jansen JP, Janssen JWM, Lugtenburg E, Span LFR, \u00d3Sullivan AK, Stam WB . Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with GvHD in the Netherlands. Bone Marrow Transplant 2008; 41 (Suppl 1): S235 (abst. P804).","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2009272_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/13693780600849113","volume":"44","author":"E Mantadakis","year":"2006","unstructured":"Mantadakis E, Samonis G . Novel preventative strategies against invasive aspergillosis. Med Mycol 2006; 44 (Suppl 1): 327\u2013332.","journal-title":"Med Mycol"},{"key":"BFbmt2009272_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ . Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133\u2013163.","journal-title":"Clin Microbiol Rev"},{"key":"BFbmt2009272_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/510592","volume":"44","author":"A Upton","year":"2007","unstructured":"Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA . Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531\u2013540.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2009272_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1086\/517849","volume":"44","author":"L Pagano","year":"2007","unstructured":"Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality\u2014SEIFEM-C Report. Clin Infect Dis 2007; 44: 1524\u20131525.","journal-title":"Clin Infect Dis"}],"updated-by":[{"DOI":"10.1038\/bmt.2009.352","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T00:00:00Z","timestamp":1273622400000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T23:11:32Z","timestamp":1710630692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BFbmt2009272"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.272","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/bmt.2009.352","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,5]]},"assertion":[{"value":"4 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}